protea biosciences group, inc.

Protea Biosciences, Inc. is a premier contract research organization (CRO) offering LC-MS and Mass Spectrometry Imaging services focused on protein characterization, proteomics, metabolomics, and small molecule analysis. Using state-of-the-art instrumentation including high resolution, accurate mass (HRAM) mass spectrometry systems, MALDI, and the LAESI® DP-1000 Direct Ionization System, Protea supports researchers’ projects by providing information to accelerate drug discovery and development. Our infrastructure and workflows enable the identification, quantification, characterization, and spatial distribution of biomolecules such as proteins, metabolites, and lipids from biological matrices. Protea’s analyses include proprietary sample preparation methods, method development, and data analysis. Our customers use this molecular information to achieve their study objectives in the fields of pharmaceutical, clinical, academic, and industrial research.


Protea offers a line of mass spectrometry standards and protein sample preparation products which include Progenta Acid Labile Surfactants, Ultrapure MALDI Matrices and mass spec grade protein standards. Protea also offers the innovative REDIchip, for matrix-free small molecule characterization and quantitation on MALDI mass spectrometers. This robust alternative to sample analysis by traditional methods requires minimal sample preparation and is also suitable for sample mixtures.

Contact us now, or browse through our website to find the specific service or product that could facilitate your research goals.



Visit our Resource Center to learn more about our technologies and capabilities.